The action of bromosalicylhydroxamic acid (T40) on the biological level of INH and on the emergence of INH-resistant bacilli in combined treatment of tuberculosis.
D001407:Bacillus; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D006801:Humans; D006877:Hydroxamic Acids; D007538:Isoniazid; D020156:Salicylic Acid; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D006877:Hydroxamic Acids; D020156:Salicylic Acid; D007538:Isoniazid
DRUG RESISTANCE, MICROBIAL; HYDROXAMIC ACID; ISONIAZID; SALICYLIC ACID; TUBERCULOSIS, PULMONARY